Drugs 3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug October 24, 2017
NASDAQ Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter October 24, 2017
Computer Snapdragon 660 Mobile Platform To Be Included in New Intrinsyc Hardware Development Kit October 24, 2017